The Effect of SARS-CoV-2 Double Vaccination on the Outcomes of Hemodialysis Patients with COVID-19: A Meta-analysis

Overview

Journal J Infect

Specialty Infectious Diseases

Date 2022 Sep 29

PMID 36174838

Authors

Guangyu Ao

Toni Li

Yushu Wang

Carolyn Tran

Ming Gao

Min Chen

Affiliations

Soon will be listed here.

Citing Articles

The effect of bebtelovimab on clinical outcomes in patients with COVID-19: A meta-analysis.

Luo J, Li T, Liu C, Wang Y, Tran C, Ao G J Infect. 2023; 87(1):68-71.

PMID: 37085048 PMC: 10114314. DOI: 10.1016/j.jinf.2023.04.010.

References

Pirklbauer M . Hemodialysis treatment in patients with severe electrolyte disorders: Management of hyperkalemia and hyponatremia. Hemodial Int. 2020; 24(3):282-289. PMC: 7496587. DOI: 10.1111/hdi.12845. View

Tang H, Tu C, Xiong F, Sun X, Tian J, Dong J . Risk factors for the mortality of hemodialysis patients with COVID-19: A multicenter study from the overall hemodialysis population in Wuhan. Semin Dial. 2021; 35(1):71-80. PMC: 8447194. DOI: 10.1111/sdi.12995. View

Frantzen L, Cavaille G, Thibeaut S, El-Haik Y . Efficacy of the BNT162b2 mRNA COVID-19 vaccine in a haemodialysis cohort. Nephrol Dial Transplant. 2021; 36(9):1756-1757. PMC: 8135401. DOI: 10.1093/ndt/gfab165. View

Tegally H, Moir M, Everatt J, Giovanetti M, Scheepers C, Wilkinson E . Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa. Nat Med. 2022; 28(9):1785-1790. PMC: 9499863. DOI: 10.1038/s41591-022-01911-2. View

Takita M, Yoshida T, Tsuchida T, Nakagama Y, Kido Y, Suzuki S . Low SARS-CoV-2 antibody titers may be associated with poor clinical outcomes for patients with severe COVID-19. Sci Rep. 2022; 12(1):9147. PMC: 9159042. DOI: 10.1038/s41598-022-12834-w. View

Ashby D, Caplin B, Corbett R, Asgari E, Kumar N, Sarnowski A . Severity of COVID-19 after Vaccination among Hemodialysis Patients: An Observational Cohort Study. Clin J Am Soc Nephrol. 2022; 17(6):843-850. PMC: 9269655. DOI: 10.2215/CJN.16621221. View

Toda M, Yoshifuji A, Kikuchi K, Koinuma M, Komatsu M, Fujii K . Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients. Clin Exp Nephrol. 2022; 26(6):571-580. PMC: 8824537. DOI: 10.1007/s10157-022-02188-y. View

Kikuchi K, Nangaku M, Ryuzaki M, Yamakawa T, Yoshihiro O, Hanafusa N . Effectiveness of SARS-CoV-2 vaccines on hemodialysis patients in Japan: A nationwide cohort study. Ther Apher Dial. 2022; 27(1):19-23. PMC: 9347603. DOI: 10.1111/1744-9987.13887. View

Espi M, Charmetant X, Barba T, Mathieu C, Pelletier C, Koppe L . A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance hemodialysis. Kidney Int. 2021; 101(2):390-402. PMC: 8628628. DOI: 10.1016/j.kint.2021.10.040. View

10.

Ao G, Li T, Wang Y, Tran C, Qi X . Lack of efficacy for sotrovimab use in patients with COVID-19: A meta-analysis. J Infect. 2022; 85(1):e10-e12. PMC: 9021041. DOI: 10.1016/j.jinf.2022.04.027. View

11.

Betjes M . Immune cell dysfunction and inflammation in end-stage renal disease. Nat Rev Nephrol. 2013; 9(5):255-65. DOI: 10.1038/nrneph.2013.44. View

12.

Marra A, Kobayashi T, Suzuki H, Alsuhaibani M, Tofaneto B, Bariani L . Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic literature review and meta-analysis. J Infect. 2022; 84(3):297-310. PMC: 8720049. DOI: 10.1016/j.jinf.2021.12.035. View

13.

Stepanova E, Isakova-Sivak I, Rudenko L . Options for the development of a bivalent vaccine against SARS-CoV-2 and influenza. Expert Rev Vaccines. 2022; 21(11):1533-1535. DOI: 10.1080/14760584.2022.2117692. View

14.

Ashby D, Caplin B, Corbett R, Asgari E, Kumar N, Sarnowski A . Outcome and effect of vaccination in SARS-CoV-2 Omicron infection in hemodialysis patients: a cohort study. Nephrol Dial Transplant. 2022; 37(10):1944-1950. PMC: 9278226. DOI: 10.1093/ndt/gfac209. View

15.

Kim S, Chung J, Talbot H, Grijalva C, Wernli K, Kiniry E . Effectiveness of two and three mRNA COVID-19 vaccine doses against Omicron- and Delta-Related outpatient illness among adults, October 2021-February 2022. Influenza Other Respir Viruses. 2023; 16(6):975-985. PMC: 9353375. DOI: 10.1111/irv.13029. View

16.

Speer C, Goth D, Benning L, Buylaert M, Schaier M, Grenz J . Early Humoral Responses of Hemodialysis Patients after COVID-19 Vaccination with BNT162b2. Clin J Am Soc Nephrol. 2021; 16(7):1073-1082. PMC: 8425619. DOI: 10.2215/CJN.03700321. View

17.

Wang F, Ao G, Wang Y, Liu F, Bao M, Gao M . Risk factors for mortality in hemodialysis patients with COVID-19: a systematic review and meta-analysis. Ren Fail. 2021; 43(1):1394-1407. PMC: 8510603. DOI: 10.1080/0886022X.2021.1986408. View

18.

Torres R, Toro L, Sanhueza M, Lorca E, Ortiz M, Pefaur J . Clinical Efficacy of SARS-CoV-2 Vaccination in Hemodialysis Patients. Kidney Int Rep. 2022; 7(10):2176-2185. PMC: 9287586. DOI: 10.1016/j.ekir.2022.07.007. View